Michael Wong

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Michael Wong

Alaunos Therapeutics, Inc. reported in an 8-K filed February 22, 2024 that Michael Wong resigned as Vice President, Finance, effective February 23, 2024.

“On February 15, 2024, Michael Wong gave notice of his resignation as Vice President, Finance, of Alaunos Therapeutics, Inc. (the "Company"), effective February 23, 2024.”

Alaunos Therapeutics, Inc. Form 8-K, filed February 22, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Michael Wong's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Alaunos Therapeutics, Inc. (TCRT)
Proxy statement

Start not stated–2024-02-23
Alaunos Therapeutics, Inc. (TCRT)
Proxy statement

Start not stated–2024-02-23

Company network

Recorded roles and call appearances connecting this person to public companies.

Alaunos Therapeutics, Inc.

TCRT

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Resigned: Vice President, Finance Alaunos Therapeutics, Inc. (TCRT)
2024-02-23